type 1 diabetes

Home/Tag: type 1 diabetes

Type 1 diabetes risk linked to intestinal viruses

Doctors can’t predict who will develop Type 1 diabetes, a chronic autoimmune disease in which one’s own immune system destroys the cells needed to control blood-sugar levels, requiring daily insulin injections and continual monitoring. Now, a new study led by Washington University School of Medicine in St. Louis has found that viruses in the intestines

Artificial Pancreas Improves Blood Sugar Control in Young Kids

Mon, 04/03/2017 - 3:23pm by The Endocrine Society An artificial pancreas, which delivers insulin in an automated way to individuals with type 1 diabetes, appears to be safe and effective for use in children ages 5 to 8 years, a new study finds. Results will be presented Tuesday at the Endocrine Society's 99th annual meeting

Bionic pancreas treats adults with type 1 diabetes

January 10, 2017 At a Glance A bionic pancreas system improved blood glucose control in adults with type 1 diabetes better than conventional insulin pump therapy. Larger and longer studies will be needed to further assess the benefits and risks of the automated system. The bionic pancreas system includes a continuous glucose monitor and a

Stem cells from diabetic patients coaxed to become insulin-secreting cells

If damaged cells are replaceable, type 1 diabetics wouldn't need insulin shots By Jim Dryden May 10, 2016 Washington University in St. Louis, The SOURCE Signaling a potential new approach to treating diabetes, researchers at Washington University School of Medicine in St. Louis and Harvard University have produced insulin-secreting cells from stem cells derived from

Johnson & Johnson, Viacyte testing possible diabetes cure

Published February 04, 2016 Associated Press Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix the life-threatening hormonal disorder. They've already begun testing it in a small number of diabetic patients. If

Bubble Technique Could Create Type 1 Diabetes Therapy

Tue, 01/26/2016 - 10:44am Ryan Bushey, Associate Editor Two new scientific papers published on Monday demonstrated tools that could result in potential therapies for patients diagnosed with type 1 diabetes, a condition in which the immune system limits the production of insulin, typically in adolescents. Previous treatments for this disease have involved injecting beta cells

Implantable ‘artificial pancreas’ could help diabetes patients control their blood sugar

Thu, 07/02/2015 - 8:48am ACS Constant glucose monitoring and frequent insulin injections could someday be replaced with an “artificial pancreas” for people with Type 1 diabetes. Credit: ratmaner/iStock/ThinkstockLiving with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the ACS journal Industrial & Engineering Chemistry Research the

A step towards a Type 1 Diabetes vaccine by using nanotherapy

June 9, 2015 (Nanowerk News) For the first time liposomes that imitate cells in the process of natural death have been used to treat Diabetes. Researchers at Germans Trias Research Institute (at UAB-Campus of International Excellence Sphere) generated liposomes in collaboration with professionals from the ICN2. PLOS ONE Journal published the work ("Use of Autoantigen-Loaded

June 9th, 2015|Categories: Diabetes|Tags: , , |

Artificial Pancreas Improves Treatment of Type 1 Diabetes

December 1, 2014 Provided by William Raillant-Clark, University of Montreal The world’s first clinical trial comparing three alternative treatments for type 1 diabetes was conducted in Montréal by researchers at the IRCM and the University of Montreal, led by endocrinologist Dr. Rémi Rabasa-Lhoret. The study confirms that the external artificial pancreas improves glucose control and reduces the risk of hypoglycemia compared to

Diabetes stem cell therapy readied

U~T San Diego, by Bradley J. Fikes ~ July 17, 2017 In an historic announcement for the stem cell field, San Diego's ViaCyte said Thursday it has applied to start human clinical trials of its treatment for Type 1 diabetes. ViaCyte grows replacement insulin-producing cells from human embryonic stem cells. The cells are packaged while